. 2022 Oct 5;2022:9385459. doi: 10.1155/2022/9385459

Table 5.

Comparison of the craniocervical flexion and 8 domain of SF 36 between the experimental and control group after 4 weeks of treatment.

Variable	Group (n = 88) Experimental = 44 Control = 44	After the 4^th week IQR	After 4^th week mean ranks	Man Whitney U	Sig. (2-tailed)
Craniocervical flexion	Experimental	26 (24 to 28)	51.6	655.5	p = 0.007, d = 0.579
Craniocervical flexion	Control	24 (24 to 26)	37.4	655.5	p = 0.007, d = 0.579
Physical functioning–SF36	Experimental	75 (60 to 85)	51.3	669.0	p = 0.012, d = 0.552
Physical functioning–SF36	Control	70 (45 to 80)	37.70	669.0	p = 0.012, d = 0.552
Role limitation due to physical health–SF36	Experimental	62.5 (50 to 100)	51.99	638.50	p = 0.05, d = 0.613
Role limitation due to physical health–SF36	Control	50 (0 to 75)	37.01	638.50	p = 0.05, d = 0.613
Role limitation due to emotional problem–SF36	Experimental	66.7 (33.3 to 100)	50.02	725.0	p = 0.035, d = 0.443
Role limitation due to emotional problem–SF36	Control	66.7 (0 to 100)	38.98	725.0	p = 0.035, d = 0.443
Energy/fatigue–SF36	Experimental	60 (50 to 75)	51	682.0	p = 0.016, d = 0.526
Energy/fatigue–SF36	Control	55 (45 to 63.75)	38	682.0	p = 0.016, d = 0.526
Emotional wellbeing–SF36	Experimental	66 (53 to 75)	52.48	617.0	p = 0.003, d = 0.657
Emotional wellbeing–SF36	Control	60 (48 to 60)	36.52	617.0	p = 0.003, d = 0.657
Social functioning–SF36	Experimental	75 (62.5 to 87.5)	53.14	588.00	p = 0.001, d = 0.718
Social functioning–SF36	Control	62.5 (50 to 75)	35.86	588.00	p = 0.001, d = 0.718
Pain–SF36	Experimental	67.5 (55 to 86.87)	49.43	751.00	p = 0.065, d = 0.393
Pain–SF36	Control	55 (55 to 77.5)	39.57	751.00	p = 0.065, d = 0.393
General health perception–SF36	Experimental	75 (50 to 83.75)	55.59	480.00	p = 0.00, d = 0.964
General health perception–SF36	Control	47.5 (40 to 60)	33.41	480.00	p = 0.00, d = 0.964